Literature DB >> 25527505

A sorting signal suppresses IFITM1 restriction of viral entry.

Kun Li1, Rui Jia2, Minghua Li1, Yi-Min Zheng1, Chunhui Miao1, Yunfang Yao2, Hong-Long Ji3, Yunqi Geng2, Wentao Qiao2, Lorraine M Albritton4, Chen Liang5, Shan-Lu Liu6.   

Abstract

The interferon-induced transmembrane proteins (IFITMs) broadly inhibit virus infections, particularly at the viral entry level. However, despite this shared ability to inhibit fusion, IFITMs differ in the potency and breadth of viruses restricted, an anomaly that is not fully understood. Here, we show that differences in the range of viruses restricted by IFITM1 are regulated by a C-terminal non-canonical dibasic sorting signal KRXX that suppresses restriction of some viruses by governing its intracellular distribution. Replacing the two basic residues with alanine (KR/AA) increased restriction of jaagsiekte sheep retrovirus and 10A1 amphotropic murine leukemia virus. Deconvolution microscopy revealed an altered subcellular distribution for KR/AA, with fewer molecules in LAMP1-positive lysosomes balanced by increased levels in CD63-positive multivesicular bodies, where jaagsiekte sheep retrovirus pseudovirions are colocalized. IFITM1 binds to cellular adaptor protein complex 3 (AP-3), an association that is lost when the dibasic motif is altered. Although knockdown of AP-3 itself decreases some virus entry, expression of parental IFITM1, but not its KR/AA mutant, potentiates inhibition of viral infections in AP-3 knockdown cells. By using the substituted cysteine accessibility method, we provide evidence that IFITM1 adopts more than one membrane topology co-existing in cellular membranes. Because the C-terminal dibasic sorting signal is unique to human IFITM1, our results provide novel insight into understanding the species- and virus-specific antiviral effect of IFITMs.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Adaptor Protein; Interferon; Intracellular Trafficking; Retrovirus; Virus Entry

Mesh:

Substances:

Year:  2014        PMID: 25527505      PMCID: PMC4326833          DOI: 10.1074/jbc.M114.630780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Authors:  Dong Jiang; Jessica M Weidner; Min Qing; Xiao-Ben Pan; Haitao Guo; Chunxiao Xu; Xianchao Zhang; Alex Birk; Jinhong Chang; Pei-Yong Shi; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.

Authors:  Jacob S Yount; Bruno Moltedo; Yu-Ying Yang; Guillaume Charron; Thomas M Moran; Carolina B López; Howard C Hang
Journal:  Nat Chem Biol       Date:  2010-07-04       Impact factor: 15.040

3.  Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.

Authors:  Jessica M Weidner; Dong Jiang; Xiao-Ben Pan; Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

4.  Study of polytopic membrane protein topological organization as a function of membrane lipid composition.

Authors:  Mikhail Bogdanov; Philip N Heacock; William Dowhan
Journal:  Methods Mol Biol       Date:  2010

5.  Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry.

Authors:  Pascale Bertrand; Marceline Côté; Yi-Min Zheng; Lorraine M Albritton; Shan-Lu Liu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

6.  Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection.

Authors:  Marceline Côté; Thomas J Kucharski; Shan-Lu Liu
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

7.  The N-terminal region of severe acute respiratory syndrome coronavirus protein 6 induces membrane rearrangement and enhances virus replication.

Authors:  Haixia Zhou; Debra Ferraro; Jincun Zhao; Snawar Hussain; Jianqiang Shao; Jonathan Trujillo; Jason Netland; Thomas Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

8.  The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Authors:  Abraham L Brass; I-Chueh Huang; Yair Benita; Sinu P John; Manoj N Krishnan; Eric M Feeley; Bethany J Ryan; Jessica L Weyer; Louise van der Weyden; Erol Fikrig; David J Adams; Ramnik J Xavier; Michael Farzan; Stephen J Elledge
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

9.  The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.

Authors:  Samad Amini-Bavil-Olyaee; Youn Jung Choi; Jun Han Lee; Mude Shi; I-Chueh Huang; Michael Farzan; Jae U Jung
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  23 in total

1.  Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.

Authors:  Graham A D Blyth; Wing Fuk Chan; Robert G Webster; Katharine E Magor
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

2.  IFITM3 requires an amphipathic helix for antiviral activity.

Authors:  Nicholas M Chesarino; Alex A Compton; Temet M McMichael; Adam D Kenney; Lizhi Zhang; Victoria Soewarna; Matthew Davis; Olivier Schwartz; Jacob S Yount
Journal:  EMBO Rep       Date:  2017-08-23       Impact factor: 8.807

3.  Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.

Authors:  Xuesen Zhao; Mohit Sehgal; Zhifei Hou; Junjun Cheng; Sainan Shu; Shuo Wu; Fang Guo; Sylvain J Le Marchand; Hanxin Lin; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 4.  Positive Regulation of the Antiviral Activity of Interferon-Induced Transmembrane Protein 3 by S-Palmitoylation.

Authors:  Shubo Wen; Yang Song; Chang Li; Ningyi Jin; Jingbo Zhai; Huijun Lu
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

5.  IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells.

Authors:  William J Melvin; Temet M McMichael; Nicholas M Chesarino; Jocelyn C Hach; Jacob S Yount
Journal:  Viruses       Date:  2015-06-12       Impact factor: 5.048

Review 6.  A Review of Functional Motifs Utilized by Viruses.

Authors:  Haitham Sobhy
Journal:  Proteomes       Date:  2016-01-21

7.  IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.

Authors:  Tina Meischel; Svenja Fritzlar; Fernando Villalon-Letelier; Melkamu B Tessema; Andrew G Brooks; Patrick C Reading; Sarah L Londrigan
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

8.  IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

Authors:  Jingyou Yu; Minghua Li; Jordan Wilkins; Shilei Ding; Talia H Swartz; Anthony M Esposito; Yi-Min Zheng; Eric O Freed; Chen Liang; Benjamin K Chen; Shan-Lu Liu
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

9.  Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.

Authors:  Jordan Wilkins; Yi-Min Zheng; Jingyou Yu; Chen Liang; Shan-Lu Liu
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

10.  Predicted protein interactions of IFITMs may shed light on mechanisms of Zika virus-induced microcephaly and host invasion.

Authors:  Madhavi K Ganapathiraju; Kalyani B Karunakaran; Josefina Correa-Menéndez
Journal:  F1000Res       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.